SAM
IMVT icon

Smartleaf Asset Management’s Immunovant IMVT Stock Holding History

Smartleaf Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05K Hold
183
– – ﹤0.01% 2534
2026
Q1 		$4.31K Buy
183
+7
+4% +$181 ﹤0.01% 2723
2025
Q4 		$4.46K Buy
176
+6
+4% +$134 ﹤0.01% 2754
2025
Q3 		$2.73K Buy
170
+137
+415% +$2.22K ﹤0.01% 2529
2025
Q2 		$531 Sell
33
-144
-81% -$2.18K ﹤0.01% 2576
2025
Q1 		$3.25K Sell
177
-206
-54% -$4.31K ﹤0.01% 2345
2024
Q4 		$9.15K Buy
383
+263
+219% +$7.46K ﹤0.01% 2027
2024
Q3 		$3.36K Buy
120
+7
+6% +$206 ﹤0.01% 2296
2024
Q2 		$2.94K Buy
+113
New +$3.21K ﹤0.01% 2065

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Smartleaf Asset Management's IMVT Position: Q2 2026 in Review

Smartleaf Asset Management held its Immunovant (IMVT) position steady in Q2 2026 at 183 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Smartleaf Asset Management first reported a position in IMVT in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.15K in Q4 2024. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Smartleaf Asset Management held 183 shares of Immunovant worth $7.05K as of Q2 2026.
  • Smartleaf Asset Management left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2534 holding.
  • Smartleaf Asset Management first reported a position in Immunovant in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Immunovant position peaked at $9.15K in Q4 2024.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.